FDA Inspection 1019264 — Busch Robert, M.D.
The FDA completed an inspection of Busch Robert, M.D. on June 29, 2017 in Albany, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 29, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Albany, NY (United States)
Additional Details
Clinical Investigator (CI)